Can PTSD Go Away? Recovery, Relapse, and Long-Term Outlook
Author: Ukrainian Psychological Hub · Published: October 9, 2026 · Editorial Policy
PTSD can go away. Some people recover so fully that they no longer meet diagnostic criteria, including after years of symptoms. Others experience substantial improvement while managing residual difficulties, and some have persistent or recurrent PTSD. Clinical research documents all these outcomes. No fixed number of months or years determines whether a person can recover.
The meaning of recovery matters. No longer having posttraumatic stress disorder does not require forgetting a traumatic experience, eliminating every painful feeling, or remaining unaffected by every reminder. Clinically meaningful progress includes reduced symptoms, restored functioning, improved relationships, safer sleep, and greater freedom to pursue ordinary goals. Evidence-based treatment can help, and natural remission also occurs. What research cannot provide is a guaranteed individual timeline or a promise that remission will last forever.
For the broader recovery and support framework, see Posttraumatic Stress Disorder (PTSD): Symptoms, Diagnosis, and Treatment.
Can PTSD Go Away Completely?
Yes. Someone who previously fulfilled the diagnostic criteria for PTSD may later no longer fulfill them. A person can retain autobiographical memories, feel sadness about what happened, and still experience sustained recovery. The NICE clinical guideline on PTSD treats PTSD as a condition for which effective care is available and explicitly calls for reassessment when symptoms persist or recur.
In clinical research, investigators commonly describe this outcome as remission rather than a permanent cure. Follow-up assessments cover a defined period; they cannot establish what will happen after a future traumatic exposure, medical illness, major stressor, or another life change. Consequently, terms such as “fully cured” should not be confused with the measurable endpoint “no longer meets PTSD criteria.”
This distinction is especially useful when a person briefly feels distressed on an anniversary or encounters a reminder after many good years. The reaction may warrant care or support, but one reaction alone cannot establish that the disorder has returned.
What Do Recovery, Remission, Treatment Response, and Recurrence Mean?
Treatment response is an improvement in symptoms following an intervention, usually measured against a threshold selected for a study or clinical service. Someone may respond substantially while still experiencing clinically significant PTSD. Response and remission are therefore different outcomes.
Remission means that a person previously diagnosed with PTSD is below the relevant diagnostic threshold or another explicitly defined remission threshold at a later point. Studies vary in whether they use clinician interviews, self-report questionnaires, symptom-count rules, or functional criteria. A person may also have partial remission with residual symptoms. A reduced self-report score is valuable evidence of change; it cannot, by itself, prove the absence of a clinical disorder.
Recovery is a wider concept involving symptom changes, health, identity, relationships, daily functioning, and personally meaningful activities. Someone may rebuild a satisfying life while continuing some symptoms, and another person may have few symptoms while still rebuilding confidence in work or intimacy. Recovery is best considered in terms of both clinical outcomes and the person's own goals.
Relapse and recurrence describe a return of symptoms or a renewed episode after improvement. The terms are not used consistently across PTSD research. The Brooks and Greenberg systematic review (2024) found major differences in definitions and measurement, making a single reliable prevalence estimate of recurrence impossible. A temporary increase in distress is not equivalent to a new diagnosable episode.
What Does Long-Term Research Reveal?
Natural remission after diagnosed PTSD
The meta-analysis by Morina and colleagues (2014) included 42 observational studies with a total of 81,642 participants who had PTSD at baseline and were observed without specific PTSD treatment. After an average of 40 months, approximately 44% no longer met PTSD case criteria. Individual study estimates ranged from 8% to 89%.
These numbers are frequently misunderstood. They describe average remission observed within diverse study populations. They are not a prediction that any particular person has a 44% chance of recovery, and they do not describe permanent cure. Study inclusion criteria, trauma types, assessments, follow-up periods, and when PTSD was first measured differed substantially. The authors also found higher remission estimates when the baseline assessment occurred within five months of trauma than when assessment began later.
A separate systematic review by Steinert and colleagues (2015) assessed the naturalistic course of PTSD over at least three years. In clinical cohorts assessed for PTSD at baseline, reported rates of stable recovery across three to seven years ranged from about 18% to 50%. Persistent and recurrent courses were also observed. The variation demonstrates why a single recovery statistic cannot describe the prognosis of all people with PTSD.
Resilience after trauma is not the same as recovery from PTSD
Research on trajectories after potentially traumatic events often includes people who never developed PTSD. Some show limited symptoms throughout, while others have early distress that resolves, persistent distress, or later-developing symptoms. These group patterns can reveal how recovery and resilience operate across populations, but the proportion of trauma-exposed people who never develop PTSD must not be described as a remission rate among people already diagnosed with the disorder.
Similarly, declining population prevalence following a disaster is different from tracking diagnosed individuals until they recover. Changes in who is assessed, when interviews occur, and whether people remain in follow-up can influence the numbers. Prognosis depends on carefully matched definitions and study populations.
We do not know one universal PTSD relapse rate
A 2024 systematic review of 35 studies could not calculate an overall PTSD recurrence rate because studies used incompatible definitions, different follow-up periods, and different denominators. The authors also found no consistently supported set of predictors of recurrence. Claims that PTSD always returns, or that it returns in a precise fixed proportion of people, exceed the available evidence.
What the evidence supports is a range of possible outcomes. Sustained remission can occur. Significant symptoms can recur. Recurrence risk has to be considered clinically in the person's circumstances rather than derived from an invented universal percentage.
How Long Does PTSD Last?
PTSD may improve within months, persist for years, or fluctuate over a longer period. The diagnostic threshold is not a forecast of duration. Under DSM-5-TR, PTSD involves qualifying traumatic exposure, symptoms across specified clusters, clinically important distress or impairment, and symptoms that persist longer than one month. Acute stress disorder has a different diagnostic period and symptom requirements. VA's explanation of PTSD criteria explains the role of timing in diagnosis.
The time since an event is also distinct from how long a person has actually met PTSD criteria. Someone may have had years of symptoms before receiving a diagnosis; another may seek help shortly after the first month. A clinician considers the present-day symptom pattern, function, safety, prior interventions, and other conditions. An experience occurring many years ago does not make treatment meaningless.
Early reactions to trauma, acute stress disorder, PTSD, and ICD-11 complex PTSD have related but distinct clinical statuses. Not every distressing response after trauma develops into PTSD. Conversely, symptoms that remain substantial and impairing deserve attention even if the person has not yet sought a formal evaluation.
Can PTSD Go Away Without Treatment?
Yes, observational research demonstrates natural remission. The Morina meta-analysis specifically addressed long-term outcomes in the absence of PTSD-specific treatment. Some people improve through changing circumstances, increased safety, supportive relationships, and time. The evidence does not identify which individual will recover naturally or when.
For recent subthreshold symptoms, active monitoring and follow-up may be appropriate. The NICE guideline recommends considering active monitoring for some people with subthreshold PTSD symptoms during the first month following trauma. That guidance cannot be generalized to established, persistent PTSD that substantially disrupts daily life.
If symptoms continue for months, worsen, or restrict work, parenting, health care, education, social contact, or relationships, assessment and evidence-based treatment are appropriate. Waiting indefinitely for spontaneous improvement risks prolonging impairment. Natural recovery is one possible course, not a reason to discourage effective intervention.
Supportive activities can improve well-being but have differing levels of evidence for treating PTSD itself. Walking, exercise, grounding, routine, or talking with a trusted person may be helpful components of care. They are not equivalent to a manualized trauma-focused psychotherapy. Self-directed intensive exposure or forcing oneself to relive traumatic memories should not be offered as a universal way to recover.
Why Do Some People Recover Faster Than Others?
Recovery reflects interacting influences rather than one cause. Potentially relevant factors include continuing danger, repeated or prolonged exposure, social support, practical security, previous trauma, available treatment, sleep disruption, physical illness, depression, and problematic substance use. Population associations do not permit a precise prediction about one person.
Ongoing threat changes the meaning of some reactions. Hypervigilance can be understandable when a person remains in an objectively unsafe environment. Psychological support may need to address access to safety, housing, medical care, social assistance, or legal protection alongside PTSD treatment. A clinical formulation must account for present conditions, not merely for memories of the past.
Co-occurring depression, substance-use problems, chronic pain, sleep disorders, and other psychiatric or medical conditions can affect both functioning and treatment priorities. They merit independent clinical consideration. A person with PTSD can experience insomnia for more than one reason; a low mood may represent trauma-related cognitions, major depression, grief, or an interaction among them. The VA/DoD guideline explicitly addresses assessment and care in the presence of comorbid conditions.
Risk factors should never be presented as destiny. People with considerable adversity can improve, and people who appear well supported may still have severe symptoms. Prognostic uncertainty reflects real variability in the evidence and the lived course of the disorder.
Which PTSD Treatments Have the Best Evidence?
Trauma-focused psychotherapy
For adults with PTSD, the 2023 VA/DoD clinical practice guideline prioritizes individual, manualized trauma-focused psychotherapy over medication when the intervention is clinically appropriate and accessible. Prolonged exposure (PE), cognitive processing therapy (CPT), and eye movement desensitization and reprocessing (EMDR) are specifically recommended. They are distinct therapies and require practitioners trained in their respective protocols.
Prolonged exposure works through carefully planned therapeutic engagement with trauma memories and reminders while addressing avoidance. Cognitive processing therapy helps people examine and revise trauma-related beliefs, including excessive guilt or self-blame and beliefs about safety and trust. EMDR uses a structured protocol including attention to traumatic memories and bilateral stimulation. These descriptions are overviews rather than instructions for independent trauma processing.
The NICE guideline similarly recommends appropriate forms of trauma-focused CBT and EMDR for specified adult PTSD presentations, with treatment delivered by trained clinicians and adapted for clinical complexity. Some people need additional sessions or coordinated care. Different techniques and models should be selected with the person's preferences, needs, and evidence in mind.
Medication
Medication may be useful for adults who prefer it, cannot access trauma-focused psychotherapy, or require additional clinical management. The VA/DoD 2023 guideline synopsis supports sertraline, paroxetine, and venlafaxine for PTSD. Treatment choice requires consideration of adverse effects, medication interactions, other diagnoses, preferences, and monitoring.
The same guideline recommends against benzodiazepines and cannabis or cannabis-derived products as PTSD treatments. Someone taking medication should consult a prescribing professional before changing or stopping it; withdrawal symptoms and recurrence of symptoms can overlap, and a gradual taper may be needed. Medication can help reduce symptoms but does not guarantee that future trauma or stress will never trigger renewed difficulties.
Online care and supportive interventions
Secure video delivery of validated trauma-focused psychotherapy can be appropriate when implemented by trained providers. The VA/DoD synopsis recognizes such delivery for certain interventions. This differs from unguided online exercises, general-purpose chatbots, wellness apps, and experimental interventions; evidence for one class does not automatically establish efficacy for another.
Sleep treatment, occupational support, peer relationships, physical activity, and symptom-management skills can complement care or target residual problems. They have varied evidence for specific outcomes and should not be described as independently proven cures for established PTSD.
Do Treatment Benefits Last for Years?
A systematic review and meta-analysis by Weber and colleagues (2021) examined 22 randomized controlled trials involving 2,638 participants with follow-up extending at least 12 months after psychological PTSD treatment. The research generally supported maintained improvements, while indicating that comparatively few studies offer very long, rigorous follow-up and that study quality and attrition matter.
The distinction between maintaining lower symptom severity and remaining in full diagnostic remission is important. Trials have different treatment populations, outcome measures, and follow-up designs. Someone who maintained substantial improvement may still report some nightmares or avoidance. A different participant may need additional care after later stress or trauma.
A long-term follow-up study of CPT and PE in female rape survivors reassessed participants years after their original randomized treatment. Many had lasting improvement, while some continued to meet PTSD criteria. Its results offer evidence of durable treatment gains in a defined clinical population; they cannot establish one permanent recovery rate applicable to everyone with PTSD.
Overall, long-term treatment research supports a meaningful prospect of durable benefit. It also supports discussing follow-up and re-entry to care, rather than treating a future difficult period as evidence that earlier therapy had no value.
Can PTSD Come Back After It Goes Away?
Yes. Symptoms can become clinically important again after a period of remission, with or without a clearly recognized new trauma. Still, the return of a distressing memory or a difficult week does not automatically demonstrate recurrence of a full disorder. Clinicians assess the pattern and duration of symptoms, associated impairment, exposure history, other explanations, and whether current diagnostic criteria are met.
Temporary symptom fluctuations can occur around holidays, anniversaries, medical procedures, bereavement, or unexpected reminders. The VA National Center for PTSD explains that anniversary reactions may occur many years later and can range from passing distress to a more serious period of difficulty. A reminder may call for self-care or support without representing a new PTSD episode.
Greater concern is warranted when nightmares, intrusive recollections, avoidance, negative changes in mood and beliefs, heightened threat responses, or sleep problems form a sustained and increasingly impairing pattern. The person may begin restricting activities, avoiding care, withdrawing from loved ones, or experiencing major disruption. A qualified assessment can determine whether PTSD has returned or whether another condition better explains the presentation.
A new traumatic event may require assessment on its own terms. “Relapse,” “retraumatization,” and “delayed expression” are not interchangeable descriptions. A professional can help establish the sequence and clinical significance of changes.
Does Having a Trigger Mean Recovery Has Failed?
No. A trauma trigger is a cue associated with a past traumatic experience. Reminders may involve sounds, smells, dates, places, physical sensations, or situations that resemble parts of the event. A person may briefly experience distress even after years of good functioning.
The important questions are how long the reaction lasts, whether symptoms accumulate across different situations, whether avoidance expands, and whether daily functioning is compromised. Feeling distressed during an anniversary is different from experiencing several weeks of impairing PTSD symptoms. VA guidance notes that some anniversary reactions diminish after a short period, while more serious difficulties deserve additional care.
A practical recovery plan may include recognizing recurring dates, arranging support when useful, and knowing when to contact a clinician. The aim is to preserve freedom and functioning rather than to organize an entire life around eliminating every possible reminder. Intentional exposure-based interventions belong within properly assessed treatment, not as a blanket self-help instruction.
How Is Sustained Remission or Recurrence Diagnosed?
A clinical evaluation examines the traumatic exposure, specific symptoms, frequency and duration, distress, impairment, medical history, psychiatric comorbidity, substance use, safety, and the person's functioning. PTSD symptoms overlap with depression, generalized anxiety, obsessive-compulsive phenomena, sleep disorders, traumatic brain injury, and some medical problems. Their presence alone is not a diagnosis.
The PTSD Checklist for DSM-5 (PCL-5) is a self-report measure used to screen for or monitor PTSD symptoms. A falling score can demonstrate improvement, but it is not sufficient to establish remission by itself. The VA's PCL-5 assessment guidance describes its application and interpretation.
The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) is a structured interview for assessing diagnosis and severity. It offers a more comprehensive clinical framework when someone needs diagnostic clarification. The VA CAPS-5 resource explains its role. Repeated structured evaluation may help distinguish a sustained response from a transient change.
DSM-5-TR and ICD-11 do not employ identical PTSD definitions. ICD-11 also recognizes complex PTSD as a separate diagnosis involving PTSD symptoms plus disturbances in self-organization, whereas DSM-5-TR does not establish complex PTSD as a separate disorder. A study based on one classification cannot automatically be mapped onto another. The VA's complex PTSD overview discusses this distinction.
Is Complex PTSD Lifelong?
Complex PTSD can improve, although the condition may involve substantial difficulties with emotion regulation, self-concept, and relationships in addition to core PTSD symptoms. Recovery may therefore mean progress across several domains over time. Its diagnostic label does not establish that lifelong impairment is inevitable.
Evidence specific to people formally meeting ICD-11 complex PTSD criteria is still developing. Studies enrolling people with “complex trauma” or repeated adversity do not necessarily measure the same diagnosis. Results for conventional PTSD treatments are relevant to clinical decisions, but rates of remission cannot be assumed identical between distinct populations and definitions. Coordinated treatment may address continuing danger, emotional difficulties, relationships, and comorbid conditions as appropriate.
The dissociative subtype of PTSD also requires careful assessment, but it does not, on its own, define an irreversible course. Persistent depersonalization or derealization may call for differential evaluation with separate dissociative disorders.
Can PTSD Recover After Ten or Twenty Years?
Yes. Current guidelines do not declare a maximum period since trauma after which evidence-based PTSD treatment becomes futile. Someone may first seek care much later because access has improved, life has become safer, symptoms have been recognized, or earlier treatment was unavailable.
A long-standing pattern of symptoms differs from delayed emergence of clinically significant symptoms, though both warrant careful assessment. New life circumstances, medical conditions, bereavement, retirement, or a fresh trauma can affect symptom expression. Older adults may benefit from attention to medical illness, sleep, pain, medicines, cognition, and their present support system as part of treatment planning.
It is appropriate to seek help regardless of how much time has passed. The goal is to understand the person's current difficulties and identify care that can improve function and well-being.
Is PTSD Recovery Linear?
Recovery frequently includes variation. Sleep may improve before trust in others; meaningful activity may return while trauma-related guilt persists. A difficult medical appointment or anniversary can cause a setback within an otherwise improving course. This complexity is consistent with both long-term observational research and treatment follow-up findings.
There is no universal evidence-based schedule of fixed “stages of trauma recovery” through which every person must pass in the same order. Staged models can help a clinician organize care for some presentations, but they should not become rigid predictions or a test of whether someone is recovering correctly. Evidence-based decisions consider diagnostic needs, current safety, functioning, and preferences.
Recovery can also become visible in the ability to ask for help, maintain relationships, engage with meaningful activities, and respond to reminders with less disruption. A single bad day does not erase such progress.
Supporting Long-Term Recovery and Planning for Setbacks
A practical plan begins with an accurate assessment and an evidence-based treatment option when PTSD remains clinically significant. Patients may ask how symptom progress will be measured, what outcomes matter beyond questionnaire scores, which therapeutic modalities are available, and what to do if residual symptoms remain.
Safety and stability often make care more accessible. Sleep routines, social connection, practical assistance, physical health care, and secure living conditions can help sustain functioning. Their benefits vary by person and situation. These supports complement rather than replace the therapies with the strongest PTSD-specific evidence.
Planning the end of formal treatment is also valuable. Patients and clinicians can discuss likely triggers, normal fluctuations, personal warning signs, how to reconnect with the service, and whether occasional follow-up is appropriate. The VA/DoD clinical practice guideline addresses maintenance planning, monitoring of symptoms, and consideration of medication discontinuation with a prescriber.
Medication changes deserve particular care. Stopping a prescription suddenly may produce discontinuation symptoms, while changing doses may affect sleep, anxiety, or other symptoms. These changes require medical discussion. One difficult day is not a reason to initiate or stop medication independently.
For families and friends, useful support includes listening without demanding a traumatic narrative, asking what assistance is welcome, respecting boundaries, and supporting continued participation in ordinary life. Family members cannot diagnose relapse through observation alone, but they can encourage an evaluation when the person is struggling.
What If Treatment Did Not Fully Work or Symptoms Return?
Incomplete response is a reason to reassess, not a verdict about the person's future. A clinician may review diagnostic accuracy, treatment dose and fidelity, access barriers, comorbid depression or substance-use problems, ongoing trauma exposure, sleep disorders, or the need for a different evidence-based intervention.
Some people benefit from another structured treatment course, coordinated medical and mental health care, an adjusted modality, or treatment targeted at remaining symptoms. Preferences and the experience of prior therapy should guide shared decision-making. The NICE guideline explicitly recommends assessment for additional treatment or support when benefit is incomplete or relapse has occurred and discusses possible booster sessions around significant dates.
If a person experiences suicidal thoughts, acute danger, severe inability to maintain safety, or another immediate crisis, urgent local emergency or crisis care is appropriate. In the United States, the 988 Suicide & Crisis Lifeline provides crisis support; readers elsewhere should contact their local emergency or crisis service. Clinicians can also collaborate on an individualized safety plan.
Frequently Asked Questions
Can PTSD go away forever?
Sustained remission over years is possible, and many people retain meaningful improvements after treatment. Available research cannot guarantee that symptoms will never return after any future event. A prior PTSD diagnosis also does not guarantee recurrence.
Can PTSD completely disappear without therapy?
Some people achieve remission without PTSD-specific treatment, as longitudinal observational research documents. Results vary considerably, and clinicians cannot reliably identify who will recover naturally. Persistent or impairing symptoms are grounds for assessment rather than indefinite waiting.
Is PTSD always a lifelong disorder?
No. There are well-documented cases of lasting improvement and loss of diagnostic status. Others experience persistent or recurring symptoms. Diagnosis alone does not establish a personal timeline.
How many years does it take for PTSD to go away?
There is no fixed number. Recovery may occur within months or over longer periods, with or without treatment. Individual prognosis depends on multiple circumstances and cannot be inferred from an average remission percentage.
Can PTSD return after successful therapy?
It can, but research has not established one reliable population-wide rate of recurrence. A temporary reminder reaction is not equivalent to a return of the full syndrome. Sustained impairment warrants clinical reassessment.
Does being triggered after years mean I have PTSD again?
Not necessarily. A reminder can cause temporary distress in someone who no longer meets diagnostic criteria. Frequency, duration, associated symptoms, functional impact, and alternative explanations matter.
Can PTSD symptoms appear years after the event?
Yes, delayed expression of clinically significant symptoms is possible. Some people also had earlier subthreshold symptoms that became more impairing later. A clinician should examine the chronology and rule out other causes.
Can someone with complex PTSD recover?
Yes, meaningful improvement is possible. Treatment may need to address both core PTSD symptoms and difficulties with emotional regulation, relationships, and self-perception. A universal recovery percentage for ICD-11 complex PTSD has not been established.
Does an improved PCL-5 score prove PTSD is gone?
No. It indicates a reduction in reported symptoms on that instrument. Diagnostic remission requires an appropriate clinical interpretation of criteria, functioning, timing, and relevant context.
What if PTSD still affects me decades later?
Assessment and evidence-based care remain options. The long interval since trauma does not automatically mean treatment is futile. A clinician can tailor a plan to current symptoms, physical health, preferences, and practical circumstances.
Is EMDR guaranteed to prevent relapse?
No treatment guarantees permanent freedom from PTSD. EMDR is an evidence-supported option for PTSD, and long-term treatment reviews describe often-maintained gains but incomplete extended follow-up evidence.
What should I do if symptoms seem to be returning?
Take notice of persistent or worsening disruption, changes in safety or life circumstances, and new co-occurring symptoms. Contact a qualified clinician for reassessment, particularly when avoidance, sleep difficulties, or functioning deteriorate. Immediate risk requires urgent local assistance.
Related Articles
For related but distinct early-life experiences, see Childhood Trauma and PTSD: What Is the Connection? and Healing From Childhood Trauma: What Recovery Can Mean and What Treatments Have Evidence.
For differential and overlapping presentations, read Anxiety and PTSD: Fear, Trauma, Avoidance, and Classification Differences and OCD and PTSD: What Is the Connection?. These are separately owned canonical topics within the English Psychology Hub.
References
American Psychological Association. (2025). Clinical practice guideline for the treatment of posttraumatic stress disorder in adults. APA PTSD guideline.
Brooks, S. K., & Greenberg, N. (2024). Recurrence of post-traumatic stress disorder: Systematic review of definitions, prevalence and predictors. BMC Psychiatry, 24, 37. https://doi.org/10.1186/s12888-023-05460-x.
Morina, N., Wicherts, J. M., Lobbrecht, J., & Priebe, S. (2014). Remission from post-traumatic stress disorder in adults: A systematic review and meta-analysis of long-term outcome studies. Clinical Psychology Review, 34, 249–255. https://doi.org/10.1016/j.cpr.2014.03.002.
National Center for PTSD. (n.d.). Clinician-Administered PTSD Scale for DSM-5 (CAPS-5). U.S. Department of Veterans Affairs. CAPS-5 assessment.
National Center for PTSD. (n.d.). PTSD Checklist for DSM-5 (PCL-5). U.S. Department of Veterans Affairs. PCL-5 assessment.
National Center for PTSD. (n.d.). Trauma reminders: Anniversaries. U.S. Department of Veterans Affairs. Anniversary reactions.
National Institute for Health and Care Excellence. (2018). Post-traumatic stress disorder (NG116). Recommendations.
Resick, P. A., et al. (2012). Long-term outcomes of cognitive-behavioral treatments for posttraumatic stress disorder among female rape survivors. Journal of Consulting and Clinical Psychology. PubMed.
Schnurr, P. P., et al. (2024). The management of posttraumatic stress disorder and acute stress disorder: Synopsis of the 2023 U.S. Department of Veterans Affairs and U.S. Department of Defense clinical practice guideline. Annals of Internal Medicine. https://doi.org/10.7326/M23-2757.
Steinert, C., et al. (2015). The course of PTSD in naturalistic long-term studies: High variability of outcomes. A systematic review. Nordic Journal of Psychiatry. PubMed.
U.S. Department of Veterans Affairs & U.S. Department of Defense. (2023). Clinical practice guideline for management of posttraumatic stress disorder and acute stress disorder. Guideline.
Weber, M., Schumacher, S., Hannig, W., Barth, J., Lotzin, A., Schäfer, I., Ehring, T., & Kleim, B. (2021). Long-term outcomes of psychological treatment for posttraumatic stress disorder: A systematic review and meta-analysis. Psychological Medicine, 51, 1420–1430. https://doi.org/10.1017/S003329172100163X.